Correlation Between Johnson Johnson and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Johnson Johnson and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Rigel Pharmaceuticals.
Diversification Opportunities for Johnson Johnson and Rigel Pharmaceuticals
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Johnson and Rigel is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Johnson Johnson and Rigel Pharmaceuticals
Considering the 90-day investment horizon Johnson Johnson is expected to generate 16.39 times less return on investment than Rigel Pharmaceuticals. But when comparing it to its historical volatility, Johnson Johnson is 5.84 times less risky than Rigel Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Rigel Pharmaceuticals is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 780.00 in Rigel Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of 1,824 from holding Rigel Pharmaceuticals or generate 233.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Johnson Johnson vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| Johnson Johnson |
| Rigel Pharmaceuticals |
Johnson Johnson and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and Rigel Pharmaceuticals
The main advantage of trading using opposite Johnson Johnson and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| Johnson Johnson vs. Capricor Therapeutics | Johnson Johnson vs. Akari Therapeutics PLC | Johnson Johnson vs. Soleno Therapeutics | Johnson Johnson vs. Bio Path Holdings |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |